Burundi is currently facing a malaria crisis that has killed nearly the same amount of people as the Ebola outbreak in the Democratic Republic of Congo.
Malaria resistance has been found to have spread rapidly from Cambodia to neighboring countries in Southeast Asia. Using genomic surveillance, researchers detected descendants of one multi-drug resistant malaria strain replacing local parasite populations in multiple countries.
A new study suggests that cutting the duration of a course in therapy to 7 days instead of 14 days and to increasing the dosage in that time period will improve patient participation to full term in anti-relapse therapy for malaria.
A new study describes the application of effective mosquito surveillance using low-cost traps and a tool that tests each mosquito’s species, feeding material, and the presence of malaria parasites. The study also provides new information that may improve understanding of how malaria is transmitted and consequently could be controlled, including that the female Anopheles mosquitoes (the ones that transmit malaria) diets are more varied than previously assumed.
The malaria vaccine RTS,S/AS01 is sustaining some efficacy up to seven years after vaccination, according to this study, which could potentially result in significant benefits to public health.
Researchers found that the Plasmodiumparasites responsible for malaria rely on human liver cell protein for their development into an infectious form.
While fewer people are dying from malaria In Africa overall, cases have not decreased. And in parts of Asia drug-resistant strains of malaria have stated to appear.
Research demonstrated that a naturally occurring fungus engineered to deliver a toxin to mosquitoes safely reduced mosquito populations by more than 99 percent in a simulated village setting in Burkina Faso.
After last reporting a malaria case in 2013, Algeria joined 37 other countries that have been certified malaria-free by the World Health Organization (WHO).
The new vaccine took 32 years of research, and cost more than $700 million has been shown to be 40 percent effective at preventing the disease over four years.